Elevated adipose and liver IRAP/oxytocinase activity may account for increased oxytocin degradation in obesity. Effect of IRAP blockade on obese phenotype
Authors: L. Gajdosechova, K. Krskova, M. Suski, S.Y. Chai, R. Olszanecki, S. Zorad
Published in: Joint meeting of the Federation of European Physiological Societies (FEPS) and the Hungarian Physiological Society,
Publication type: conference